Pharmacokinetic Study of Dexmedetomidine After Intra-Nasal and Buccal Dosing in Children

NCT03668951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Heart Diseases

Interventions

DRUG: Dexmedetomidine buccal
DRUG: Dexmedetomidine Intranasal
DRUG: Dexmedetomidine Intranasal

Sponsor

Children's Hospital Medical Center, Cincinnati